Špela Zupančič
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Špela Zupančič has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Julijana Kristl
University of Ljubljana
14 shared publications - Anže Zidar
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia
5 shared publications - Matjaž Jeras
Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana, Slovenia
5 shared publications Nina Katarina Grilc
4 shared publications- Petra Kocbek
Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia
4 shared publications - Aleš Berlec
Department of Biotechnology, Jožef Stefan Institute, Jamova 39, Ljubljana, Slovenia
3 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 125
Crystallization of low molecular weight stabilizers in polymeric nanofibers during storage
- 2 July 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 125
Open AccessCrystallization of low molecular weight stabilizers in polymeric nanofibers during storage
- Open Access
- 15 September 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 328 (Pt 2) , 147562
Adaptive immune cell reactivity to polycaprolactone, alginate, chitosan, and zein nanofibers
- 15 September 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 328 (Pt 2) , 147562
Open AccessAdaptive immune cell reactivity to polycaprolactone, alginate, chitosan, and zein nanofibers
- Open Access
- 14 February 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 673, 125327
Viability of potential probiotics incorporated into nanofibers: Influence of genera, storage conditions, stabilizers and their solid-state
- 14 February 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 673, 125327
Open AccessViability of potential probiotics incorporated into nanofibers: Influence of genera, storage conditions, stabilizers and their solid-state
- 1 January 2025
- Published by University of Szeged
How stable are stabilizers?
- Open Access
- 30 October 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 282 (Pt 3) , 137029
Impact of polycaprolactone, alginate, chitosan and zein nanofiber physical properties on immune cells for safe biomedical applications
- 30 October 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 282 (Pt 3) , 137029
Open AccessImpact of polycaprolactone, alginate, chitosan and zein nanofiber physical properties on immune cells for safe biomedical applications
- Open Access
- 21 October 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 245, 114329
Can polymeric nanofibers effectively preserve and deliver live therapeutic bacteria?
- 21 October 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 245, 114329
Open AccessCan polymeric nanofibers effectively preserve and deliver live therapeutic bacteria?
- Open Access
- 10 December 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 650, 123696
Development of a novel in vitro cell model for evaluation of nanofiber mats immunogenicity
- 10 December 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 650, 123696
Open AccessDevelopment of a novel in vitro cell model for evaluation of nanofiber mats immunogenicity
- Open Access
- 14 April 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (4) , 1245
Development of Nanofibers with Embedded Liposomes Containing an Immunomodulatory Drug Using Green Electrospinning
Conventional treatments for chronic wounds are often ineffective, thus new therapeutic approaches are needed, such as the delivery of immunomodulatory drugs that can reduce inflammation, restore immune cell function, and facilitate tissue regeneration. A potential drug for such an approach is simvastatin, which has major drawbacks including poor solubility and chemical instability. With the aim of developing a dressing for wound healing, simvastatin and an antioxidant were incorporated into alginate/poly(ethylene oxide) nanofibers by green electrospinning without the use of organic solvents, thanks to their prior encapsulation into liposomes. The composite liposome–nanofiber formulations exhibited fibrillar morphology (160–312 nm) and unprecedentedly high phospholipid and drug content (76%). Transmission electron microscopy revealed dried liposomes as bright ellipsoidal spots homogeneously distributed over the nanofibers. After nanofiber hydration, the liposomes reconstituted in two size populations (~140 and ~435 nm), as revealed by cutting-edge MADLS® analysis. Lastly, in vitro assays demonstrated that composite liposome–nanofiber formulations are superior to liposomal formulations due to a better safety profile in keratinocytes and peripheral blood mononuclear cells. Furthermore, both formulations exhibited similarly advantageous immunomodulatory effects, measured as decreased inflammation in vitro. A synergistic combination of the two nanodelivery systems shows promise for the development of efficient dressings for chronic wound treatment.
- 14 April 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (4) , 1245
Open AccessDevelopment of Nanofibers with Embedded Liposomes Containing an Immunomodulatory Drug Using Green Electrospinning
Conventional treatments for chronic wounds are often ineffective, thus new therapeutic approaches are needed, such as the delivery of immunomodulatory drugs that can reduce inflammation, restore immune cell function, and facilitate tissue regeneration. A potential drug for such an approach is simvastatin, which has major drawbacks including poor solubility and chemical instability. With the aim of developing a dressing for wound healing, simvastatin and an antioxidant were incorporated into alginate/poly(ethylene oxide) nanofibers by green electrospinning without the use of organic solvents, thanks to their prior encapsulation into liposomes. The composite liposome–nanofiber formulations exhibited fibrillar morphology (160–312 nm) and unprecedentedly high phospholipid and drug content (76%). Transmission electron microscopy revealed dried liposomes as bright ellipsoidal spots homogeneously distributed over the nanofibers. After nanofiber hydration, the liposomes reconstituted in two size populations (~140 and ~435 nm), as revealed by cutting-edge MADLS® analysis. Lastly, in vitro assays demonstrated that composite liposome–nanofiber formulations are superior to liposomal formulations due to a better safety profile in keratinocytes and peripheral blood mononuclear cells. Furthermore, both formulations exhibited similarly advantageous immunomodulatory effects, measured as decreased inflammation in vitro. A synergistic combination of the two nanodelivery systems shows promise for the development of efficient dressings for chronic wound treatment.
- Open Access
- 10 February 2023
- Published by Elsevier in Journal of Controlled Release
- Vol. 355, 371-384
Nanofibers with genotyped Bacillus strains exhibiting antibacterial and immunomodulatory activity
- 10 February 2023
- Published by Elsevier in Journal of Controlled Release
- Vol. 355, 371-384
Open AccessNanofibers with genotyped Bacillus strains exhibiting antibacterial and immunomodulatory activity
- Open Access
Incorporation of Ethylcellulose Microparticles Containing a Model Drug with a Bitter Taste into Nanofibrous Mats by the Electrospinning Technique—Preliminary Studies
Electrospinning is considered a simple and comprehensive technique to formulate ultrafine fibres by using an electric field. Polymeric nanofibers constitute promising materials in biomedical applications as drug delivery systems. For their preparation, both natural and synthetic polymers are utilised. Owing to the potential use of electrospun nanofibers as an orodispersible drug dosage form, ethylcellulose microparticles containing the antihistamine drug rupatadine fumarate, prepared by the spray drying technique to conceal the drug’s bitter taste, were incorporated into nanofibers. The obtained nanofibrous mats were evaluated for morphology, mechanical strength, disintegration time, the drug solid state and acceptability in terms of taste masking efficiency. Preliminary studies showed that hypromellose used as a single polymer was not a suitable substance for the manufacturing of nanofibers. Therefore, in order to facilitate the obtention of homogeneous nonwovens, different grades of polyethylene oxide (2,000,000–2M-Da and 4,000,000–4M-Da) were added, which improved the quality of the prepared mats. Nanofibers of the most satisfactory quality were obtained from hypromellose (6.5% w/v) and PEO (2M, 0.5% w/v). SEM image analysis has shown that the nanofibers were homogeneous and smooth and possessed a fast disintegration time (below 30 s) and an adequate drug content with a simultaneous taste-masking effect (as indicated by the in vivo and in vitro methods). However, further studies are necessary to refine their mechanical characteristics.
Open AccessIncorporation of Ethylcellulose Microparticles Containing a Model Drug with a Bitter Taste into Nanofibrous Mats by the Electrospinning Technique—Preliminary Studies
Electrospinning is considered a simple and comprehensive technique to formulate ultrafine fibres by using an electric field. Polymeric nanofibers constitute promising materials in biomedical applications as drug delivery systems. For their preparation, both natural and synthetic polymers are utilised. Owing to the potential use of electrospun nanofibers as an orodispersible drug dosage form, ethylcellulose microparticles containing the antihistamine drug rupatadine fumarate, prepared by the spray drying technique to conceal the drug’s bitter taste, were incorporated into nanofibers. The obtained nanofibrous mats were evaluated for morphology, mechanical strength, disintegration time, the drug solid state and acceptability in terms of taste masking efficiency. Preliminary studies showed that hypromellose used as a single polymer was not a suitable substance for the manufacturing of nanofibers. Therefore, in order to facilitate the obtention of homogeneous nonwovens, different grades of polyethylene oxide (2,000,000–2M-Da and 4,000,000–4M-Da) were added, which improved the quality of the prepared mats. Nanofibers of the most satisfactory quality were obtained from hypromellose (6.5% w/v) and PEO (2M, 0.5% w/v). SEM image analysis has shown that the nanofibers were homogeneous and smooth and possessed a fast disintegration time (below 30 s) and an adequate drug content with a simultaneous taste-masking effect (as indicated by the in vivo and in vitro methods). However, further studies are necessary to refine their mechanical characteristics.